Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Mini brains 'could transform drug testing'

22 February 2016

By Dr Lanay Griessner

Appeared in BioNews 840

Miniature brains made out of clusters of human cells could revolutionise high-throughput drug screening, said scientists at the American Association for the Advancement of Science annual meeting in Washington, DC, earlier this month. 

'Ninety-five percent of drugs that look promising when tested in animal models fail once they are tested in humans, at great expense of time and money,' said study leader Dr Thomas Hartung from the Johns Hopkins Bloomberg School of Public Health at a press conference.

Dr Hartung and colleagues created the mini-brains using skin cells from adult volunteers. These cells are reprogrammed back into stem cells, which are then induced to grow into brain cells. Within two months they grew into three-dimensional clusters approximately the size of a housefly's eye.

Despite their tiny size, these mini-brains are surprisingly complex and are able to replicate some primitive brain functions. They include four distinct types of neurons as well as two different supporting cells – including oligodendrocytes, which create the protective myelin sheath surrounding neurons. The mini-brains even show spontaneous electrophysiological activity in response to various drugs similar to what might be seen on an electroencephalogram (EEG). 

Researchers think that mini-organs may better represent how normal human brains react to specific drugs and could therefore provide a viable alternative to animal models.

'While rodent models have been useful, we are not 150-pound rats. And even though we are not balls of cells either, you can often get much better information from these balls of cells than from rodents,' Dr Hartung told Motherboard.

Experiments using mini-brains could also be used for basic research, providing insight into neurodegenerative diseases such as Alzheimer's and Parkinson's disease, stroke and trauma.

'We don't have the first brain model, nor are we claiming to have the best one. But this is the most standardised one. And when testing drugs it is imperative that the cells being studied are as similar as possible to ensure the most comparable and accurate results,' said Dr Hartung.

The method is also scalable, with the possibility of generating hundreds of mini-brains from the same batch of cells.

'Nobody should have an excuse to still use the old animal models,' said Dr Hartung.

Dr Hartung's team is currently creating a spin-off company called Organome, which aims to make mini-brains available for pharmaceutical testing within the next year.

SOURCES & REFERENCES
Financial Times | 12 February 2016
 
The Telegraph | 12 February 2016
 
Motherboard | 14 February 2016
 
Eurekalert (press release) | 12 February 2016
 
AAAS Annual Meeting 2016 (conference paper) | 13 February 2016
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

11 July 2016 - by Sarah Gregory 
Researchers looking at multiple genes have developed risk scores that could identify those most likely to develop Alzheimer's disease in later life...

12 October 2015 - by Rhys Baker 
Australian scientists have successfully grown 'mini kidneys' from stem cells derived from skin tissue...
24 August 2015 - by Dr Julia Hill 
For the first time, an almost fully formed human brain has been grown in the lab, according to scientists from Ohio State University...
20 July 2015 - by Ayala Ochert 
Scientists have grown miniature brains out of stem cells from people with autism, and have found that they over-produce one type of neuron...
03 November 2014 - by Antony Blackburn-Starza 
Scientists in the USA have for the first time created three-dimensional stomach tissue from human pluripotent stem cells...
02 September 2013 - by Dr Sophie Pryor 
Human stem cells have been used to grow miniature brains, 'organoids' that are just millimetres across and at an equivalent developmental stage as in a nine-week-old fetus...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation